AI summary · may contain errors
Programmed cell death research is being reframed around translating underlying mechanisms into effective therapies, with a focus on future directions and key translational challenges.
- Open access
Moving in bioRxiv, Leukemia, Oncogene, Cell Death & Differentiation, Clinical Cancer Research, JNCI: Journal of the National Cancer Institute, EMBO Journal and Genetics.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Programmed cell death research is being reframed around translating underlying mechanisms into effective therapies, with a focus on future directions and key translational challenges.
AI summary · may contain errors
p21 variants modulate CDK-cyclin complex formation in living cells, with FLIM-FRET showing increased CDK4–cyclin D3 and CDK2–cyclin E1 interactions depending on p21’s redox state and PTMs.
AI summary · may contain errors
In E μ-Myc transgenic mice, inhibiting apoptosis with BCL2 does not allow CIN-driven aneuploidies to prevail, but high death rates rapidly select viable aneuploid karyotypes.
AI summary · may contain errors
A threshold-based protein ensemble model predicts the time to death of stimulated B and T lymphocytes, using single-cell BCL-2 family protein levels and a critical cutoff.
AI summary · may contain errors
Inducible E2F1 expression drives exit from quiescence and a G0–G1 reentry transcriptional program without altering chromatin accessibility in quiescent cells.
AI summary · may contain errors
DDR signaling is shown in Saccharomyces cerevisiae to propagate through a protein kinase cascade, initiated by RPA binding to ssDNA and activating MEC1/ATR.
AI summary · may contain errors
E2F3 generates two major isoforms, E2F3A and E2F3B, whose N-terminal differences are linked to overlapping and isoform-specific roles in cell cycle control and oncogenesis.
AI summary · may contain errors
JNK activation sustains CDC73 stability in osteosarcoma by antagonizing UBR5-mediated CDC73 polyubiquitination, with Lys257 identified as the key ubiquitination residue.
AI summary · may contain errors
MDM2 promotes K48-linked polyubiquitination of MEIS1 at K178, driving MEIS1 proteasomal degradation and enabling p53 activation in the DNA damage response.
AI summary · may contain errors
UBASHIN, a small-molecule inhibitor of the UBASH3B 2HP domain, phenocopies UBASH3B depletion by mislocalizing Aurora B, triggering mitotic arrest and mitotic cell death.
AI summary · may contain errors
SETDB1 promotes colorectal cancer progression by partnering with the CRL4B complex to repress core clock genes, disrupting circadian rhythms and accelerating proliferation and metastasis.
AI summary · may contain errors
DPB is a covalent molecular glue that selectively kills p53-deficient NSCLC by recruiting RPS7 to MKRN2, enabling RPS7 ubiquitination and proteasomal degradation.
AI summary · may contain errors
Cyclin D uses its A2' helix to dock the retinoblastoma protein Rb, and mutating this unique interface slows proliferation in the studied system.
AI summary · may contain errors
FKBPL is significantly elevated in hepatocellular carcinoma and is linked to poor prognosis, and its loss suppresses HCC viability and xenograft tumour growth.
AI summary · may contain errors
Human Orc6 is linked to weaker Orc6–ORC(1-5) interactions than Drosophila, but its strong nuclear localization signal may compensate by promoting fully assembled ORC complex formation at DNA.
AI summary · may contain errors
E2 from papillomaviruses activates an ATM-high, ATR-low DNA damage response by displacing CIP2A from TOPBP1, linked to CIP2A-mediated PP2A inhibition and ATM activation.
AI summary · may contain errors
Cre-mediated EGFRvIII overexpression with homozygous p19-ARF deletion in GFAP-expressing glial cells produces spontaneous classical glioblastoma lesions, with 95% of mice reaching endpoint symptoms by 6 months.
AI summary · may contain errors
In SAC-deficient Cdc20ΔFL cells, Mad2 becomes dispensable for viability, while combined control of APC/C-Cdc20 timing still prevents premature mitotic exit and chromosome mis-segregation.
AI summary · may contain errors
TP53 mutation in colorectal cancer organoids is almost confined to MDM2 P1-dominant samples (40 of 42), and morphology shifts with TP53 status.
AI summary · may contain errors
WEE1 promotes S phase re-entry from quiescence by phosphorylating CDH1 (FZR1) to oppose APC/C(CDH1) activity, and loss of WEE1 delays S phase entry.
AI summary · may contain errors
In a multicenter European NSCLC cohort (n=28,244), TP53 Y220C was found in 195 patients (0.7%), with prevalence higher than solid tumors overall (0.4%).
Journals this month
Topics moving, week to 19 Nov 2026
By field